Myriad Genetics reported $367.1M in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Accelerate Diagnostics AXDX:US 48.06M 13.05M
Agilent A:US $ 3690M 47M
Becton, Dickinson and BDX:US $ 9547M 605M
Bio Rad Laboratories BIO:US $ 3249.7M 53.72M
Biocept BIOC:US $ 47.58M 1.89M
Bruker BRKR:US $ 2087.5M 163.3M
Danaher DHR:US $ 13229M 559M
Exact Sciences EXAS:US $ 1101.63M 113.5M
Fluidigm FLDM:US $ 250.88M 177.68M
Hologic HOLX:US $ 3909M 27.6M
Illumina ILMN:US $ 2891M 136M
Mettler Toledo International MTD:US 1.32B 14.82M
Myriad Genetics MYGN:US $ 367.1M 60.3M
Nanostring Technologies NSTG:US $ 354.7M 32.43M
Orasure Technologies OSUR:US $ 267.31M 1.06M
Pacific Biosciences Of California PACB:US $ 969.99M 59.2M
Perkinelmer PKI:US $ 2107.77M 346.74M
Quest Diagnostics DGX:US $ 2426M 49M
Quidel QDEL:US $ 1559.1M 554.55M
Repligen RGEN:US $ 976M 31.21M
Thermo Fisher Scientific TMO:US $ 18100M 676M
Veracyte VCYT:US $ 235.04M 3.44M
Waters WAT:US $ 1469.17M 116.01M